Cargando…

Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis

BACKGROUND: Assessment of design heterogeneity conducted prior to meta-analysis is infrequently reported; it is often presented post hoc to explain statistical heterogeneity. However, design heterogeneity determines the mix of included studies and how they are analyzed in a meta-analysis, which in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Althuis, Michelle D, Weed, Douglas L, Frankenfeld, Cara L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128504/
https://www.ncbi.nlm.nih.gov/pubmed/25055879
http://dx.doi.org/10.1186/2046-4053-3-80
_version_ 1782330131134545920
author Althuis, Michelle D
Weed, Douglas L
Frankenfeld, Cara L
author_facet Althuis, Michelle D
Weed, Douglas L
Frankenfeld, Cara L
author_sort Althuis, Michelle D
collection PubMed
description BACKGROUND: Assessment of design heterogeneity conducted prior to meta-analysis is infrequently reported; it is often presented post hoc to explain statistical heterogeneity. However, design heterogeneity determines the mix of included studies and how they are analyzed in a meta-analysis, which in turn can importantly influence the results. The goal of this work is to introduce ways to improve the assessment and reporting of design heterogeneity prior to statistical summarization of epidemiologic studies. METHODS: In this paper, we use an assessment of sugar-sweetened beverages (SSB) and type 2 diabetes (T2D) as an example to show how a technique called ‘evidence mapping’ can be used to organize studies and evaluate design heterogeneity prior to meta-analysis.. Employing a systematic and reproducible approach, we evaluated the following elements across 11 selected cohort studies: variation in definitions of SSB, T2D, and co-variables, design features and population characteristics associated with specific definitions of SSB, and diversity in modeling strategies. RESULTS: Evidence mapping strategies effectively organized complex data and clearly depicted design heterogeneity. For example, across 11 studies of SSB and T2D, 7 measured diet only once (with 7 to 16 years of disease follow-up), 5 included primarily low SSB consumers, and 3 defined the study variable (SSB) as consumption of either sugar or artificially-sweetened beverages. This exercise also identified diversity in analysis strategies, such as adjustment for 11 to 17 co-variables and a large degree of fluctuation in SSB-T2D risk estimates depending on variables selected for multivariable models (2 to 95% change in the risk estimate from the age-adjusted model). CONCLUSIONS: Meta-analysis seeks to understand heterogeneity in addition to computing a summary risk estimate. This strategy effectively documents design heterogeneity, thus improving the practice of meta-analysis by aiding in: 1) protocol and analysis planning, 2) transparent reporting of differences in study designs, and 3) interpretation of pooled estimates. We recommend expanding the practice of meta-analysis reporting to include a table that summarizes design heterogeneity. This would provide readers with more evidence to interpret the summary risk estimates.
format Online
Article
Text
id pubmed-4128504
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41285042014-08-12 Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis Althuis, Michelle D Weed, Douglas L Frankenfeld, Cara L Syst Rev Methodology BACKGROUND: Assessment of design heterogeneity conducted prior to meta-analysis is infrequently reported; it is often presented post hoc to explain statistical heterogeneity. However, design heterogeneity determines the mix of included studies and how they are analyzed in a meta-analysis, which in turn can importantly influence the results. The goal of this work is to introduce ways to improve the assessment and reporting of design heterogeneity prior to statistical summarization of epidemiologic studies. METHODS: In this paper, we use an assessment of sugar-sweetened beverages (SSB) and type 2 diabetes (T2D) as an example to show how a technique called ‘evidence mapping’ can be used to organize studies and evaluate design heterogeneity prior to meta-analysis.. Employing a systematic and reproducible approach, we evaluated the following elements across 11 selected cohort studies: variation in definitions of SSB, T2D, and co-variables, design features and population characteristics associated with specific definitions of SSB, and diversity in modeling strategies. RESULTS: Evidence mapping strategies effectively organized complex data and clearly depicted design heterogeneity. For example, across 11 studies of SSB and T2D, 7 measured diet only once (with 7 to 16 years of disease follow-up), 5 included primarily low SSB consumers, and 3 defined the study variable (SSB) as consumption of either sugar or artificially-sweetened beverages. This exercise also identified diversity in analysis strategies, such as adjustment for 11 to 17 co-variables and a large degree of fluctuation in SSB-T2D risk estimates depending on variables selected for multivariable models (2 to 95% change in the risk estimate from the age-adjusted model). CONCLUSIONS: Meta-analysis seeks to understand heterogeneity in addition to computing a summary risk estimate. This strategy effectively documents design heterogeneity, thus improving the practice of meta-analysis by aiding in: 1) protocol and analysis planning, 2) transparent reporting of differences in study designs, and 3) interpretation of pooled estimates. We recommend expanding the practice of meta-analysis reporting to include a table that summarizes design heterogeneity. This would provide readers with more evidence to interpret the summary risk estimates. BioMed Central 2014-07-23 /pmc/articles/PMC4128504/ /pubmed/25055879 http://dx.doi.org/10.1186/2046-4053-3-80 Text en Copyright © 2014 Althuis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Althuis, Michelle D
Weed, Douglas L
Frankenfeld, Cara L
Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
title Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
title_full Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
title_fullStr Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
title_full_unstemmed Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
title_short Evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
title_sort evidence-based mapping of design heterogeneity prior to meta-analysis: a systematic review and evidence synthesis
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128504/
https://www.ncbi.nlm.nih.gov/pubmed/25055879
http://dx.doi.org/10.1186/2046-4053-3-80
work_keys_str_mv AT althuismichelled evidencebasedmappingofdesignheterogeneitypriortometaanalysisasystematicreviewandevidencesynthesis
AT weeddouglasl evidencebasedmappingofdesignheterogeneitypriortometaanalysisasystematicreviewandevidencesynthesis
AT frankenfeldcaral evidencebasedmappingofdesignheterogeneitypriortometaanalysisasystematicreviewandevidencesynthesis